Black checkmark with a sparkle and a curved line underneath on a white background.
Company

Identiv, Inc.

Ticker
INVE
Sector
Industry
Report date
November 14, 2026
Valye AI Score

93

Very high visibility
Recent developments
Recent developments summary

Recent developments include multiple earnings call transcripts for Q1 and Q3 2026, a $20 million tender offer announcement, and ongoing disclosures of preliminary quarterly results.

Recent developments:
  • Identiv announced a $20 million tender offer and preliminary third quarter 2026 results in October 2026 [N3].
  • The company held Q3 2026 earnings calls providing detailed operational and financial commentary in November 2026 [N1][N2].
  • Q1 2026 earnings transcripts and call highlights were published in May 2026, discussing financial results and strategic initiatives [N5][N6][N7].
Overview

Identiv, Inc. is a publicly traded technology company listed on Nasdaq under the ticker INVE. The company has a board of directors with diverse expertise in healthcare, technology, and finance, including CEO Kirsten F. Newquist who has led the company since September 2024. Identiv's business focus includes digital identification solutions and healthcare verticals, supported by leadership experience and strategic board members. The company maintains a strong liquidity position with cash and equivalents of approximately $86.8 million as of September 30, 2026, and a current ratio of 12.54, indicating solid short-term financial health. Recent corporate actions include a $20 million tender offer and multiple earnings call disclosures providing transparency into operational performance and strategy.

Executive summary

Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Identiv, Inc. is a Nasdaq-listed technology company with detailed disclosures in its 2025 10-K/A and 2026 Q3 10-Q filings. The company reported $86.8 million in cash and equivalents and a net income of $588,000 for Q3 2026. The board comprises experienced executives with expertise in healthcare and technology sectors. Recent news includes earnings call transcripts and a $20 million tender offer announcement [S1][S2][N1][N3].

Scenarios for INVE

Bull case model:

Identiv benefits from a strong liquidity position and a seasoned leadership team with extensive experience in healthcare and technology sectors. The company's strategic focus on digital identification and healthcare verticals aligns with growing industry demand for secure and innovative technology solutions. Recent corporate actions such as the $20 million tender offer demonstrate active capital management. The board's composition with members experienced in scaling businesses and driving innovation supports potential operational execution and growth initiatives.

Bear case model:

The company has limited recent revenue disclosure and reported modest net income for Q3 2026, which may indicate challenges in scaling or profitability. The absence of detailed financial metrics such as long-term revenue trends or margins constrains visibility into business performance. Market and technology sector competition, along with reliance on successful execution of strategic initiatives, pose risks. Additionally, the company's relatively small scale and evolving business model may face headwinds from macroeconomic or industry-specific factors.

Moat:

Identiv's moat is supported by its specialized focus on digital identification and healthcare technology solutions, leveraging the expertise of its leadership and board members with deep industry experience. The company's ability to integrate innovative technology into healthcare verticals and its strategic governance structure contribute to competitive differentiation. However, detailed information on proprietary technology, patents, or customer contracts is not explicitly disclosed in the available filings, limiting a full assessment of sustainable competitive advantages.

Risks overview
Risks summary
Execution risks related to scaling the business and achieving sustained profitability amid competitive and regulatory challenges represent the primary risks for Identiv.
Risks details:

• Market and Competitive Risks: Identiv operates in competitive technology and healthcare sectors where rapid innovation and market shifts can impact business performance.
• Execution Risks: The company’s ability to scale operations, manage costs, and successfully commercialize technology solutions is critical to financial outcomes.
• Financial Risks: Limited recent revenue disclosure and modest net income highlight potential challenges in achieving sustained profitability.
• Regulatory and Industry Risks: Operating in healthcare-related verticals may expose the company to regulatory changes and compliance requirements.

FINAL FORECAST FOR INVE

Final take one line
Identiv, Inc. demonstrates very high visibility through detailed SEC filings and recent earnings disclosures, highlighting a strong liquidity position and experienced leadership amid evolving business execution.
Final take 12 to 24 month view

Business trends: The company focuses on digital identification and healthcare technology sectors with ongoing capital management and operational disclosures.
Execution milestones: Recent earnings calls and a $20 million tender offer reflect active financial and strategic management.
Key risks: Execution challenges in scaling the business and achieving sustained profitability amid competitive and regulatory environments.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

93
LLM visibility overview
LLM Visibility known facts
  • Identiv, Inc. is a publicly traded company on Nasdaq under the ticker INVE [S1].
  • The company filed an amended annual report (10-K/A) for fiscal year ended December 31, 2025, disclosing detailed governance, executive leadership, and board composition [S1].
  • As of April 15, 2026, Identiv had 24,002,872 shares outstanding excluding 2,787,285 shares held in treasury [S1].
  • The board of directors includes experienced executives with backgrounds in healthcare, technology, finance, and corporate governance, including CEO Kirsten F. Newquist since September 2024 [S1].
  • The company reported financial results in a 10-Q filing for the quarter ended September 30, 2026, including cash and equivalents of $86.8 million, current assets of $88.5 million, and current liabilities of $7.1 million, yielding a current ratio of 12.54 and cash ratio of 12.3 [S2].
  • Net income for Q3 2026 was $588,000 with basic and diluted EPS of $0.02 [S2].
  • Revenue data is limited in recent filings but historical revenue of $20.3 million was reported for Q2 2018 [S2].
  • Recent news includes multiple earnings call transcripts and announcements such as a $20 million tender offer and preliminary Q3 2026 results [N1][N2][N3].
  • The company operates in technology sectors with a focus on healthcare verticals and digital identification solutions as indicated by board expertise and CEO background [S1].
  • Liquidity position is strong as of September 30, 2026, with substantial cash and current assets relative to liabilities [S2].
Sources
Sources - Context summary

Generated 2026-11-14

Sources - Earning calls
  • N1
  • N2
  • N5
  • N6
  • N7
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-04-29 | 10-K/A
  • S2 | 2026-11-13 | 10-Q
Sources - News headlines
  • N1 | 2026-11-13 | www.nasdaq.com | INVE Tech (INVE) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/inve-tech-inve-q3-2026-earnings-call-transcript
  • N2 | 2026-11-13 | www.nasdaq.com | What INVE Technologies (INVE) Said on Its Q3 Earnings Call | https://www.nasdaq.com/articles/what-inve-technologies-inve-said-its-q3-earnings-call
  • N3 | 2026-10-21 | www.nasdaq.com | Identiv, Inc. Commences $20 Million Tender Offer and Announces Preliminary Third Quarter 2026 Results | https://www.nasdaq.com/articles/identiv-inc-commences-20-million-tender-offer-and-announces-preliminary-third-quarter-2026
  • N4 | 2026-08-07 | www.nasdaq.com | Turtle Beach (TBCH) Reports Q2 Loss, Misses Revenue Estimates | https://www.nasdaq.com/articles/turtle-beach-tbch-reports-q2-loss-misses-revenue-estimates
  • N5 | 2026-05-15 | www.nasdaq.com | Identiv (INVE) Q1 2026 Earnings Transcript | https://www.nasdaq.com/articles/identiv-inve-q1-2026-earnings-transcript
  • N6 | 2026-05-14 | www.nasdaq.com | Identiv Q1 Earnings Call Highlights | https://www.nasdaq.com/articles/identiv-q1-earnings-call-highlights
  • N7 | 2026-05-13 | www.nasdaq.com | Identiv, Inc. (INVE) Reports Q1 Loss, Tops Revenue Estimates | https://www.nasdaq.com/articles/identiv-inc-inve-reports-q1-loss-tops-revenue-estimates
  • N8 | 2026-05-07 | www.nasdaq.com | Turtle Beach (TBCH) Reports Q1 Loss, Misses Revenue Estimates | https://www.nasdaq.com/articles/turtle-beach-tbch-reports-q1-loss-misses-revenue-estimates
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine